Pall Life Sciences

Dec 01, 2005
By BioPharm International Editors
Volume 18, Issue 12

Company Description

Pall is a leading global provider of filtration, purification, and separation technologies to the diverse and rapidly expanding life sciences market. Its products are used from the earliest stages of discovery and development of new drugs, through production and delivery of therapies for the prevention, diagnosis, and treatment of disease.

In the laboratory, Pall products help facilitate the drug discovery and development process to get innovative drugs to the market faster. In biopharmaceuticals, Pall products are applicable to laboratory- and pilot-scale development, aseptic processing, biologicals, bioprocessing, fermentation and downstream processing. In medical and transfusion medicine, Pall is a market leader in blood filtration systems to improve the quality and safety of the world's blood supply, and in medical filters that enhance the safety of cardiac surgery, drug delivery, intravenous feeding and accuracy of diagnostic tests.

Technical Services

Pall offers process development and process validation services together with pre-inspection reviews, as well as troubleshooting consultancy, training, contamination analysis and other technical assistance. Additional services are protein expression monitoring and multi-step chromatography purification development, target and impurity tracking and host cell protein assay development, purification optimization, and custom affinity sorbents.

Corporate Facilities

Pall maintains manufacturing facilities certified to ISO9001 in the United States, Puerto Rico, England, Ireland, France, Germany, Japan, India, and China.

Major Products

Pall Life Sciences provides membrane and membrane devices to optimize detection and sample preparation in basic drug research, clinical diagnostics, combinatorial chemistry and high throughput screening, as well as in the growing genomics and proteomics markets.

In pharmaceutical and bioprocess manufacturing, Pall offers full capability in chromatography and filtration. Pall's direct and tangential flow filtration technologies are used for biomass removal, clarification, particulate and bioburden reduction, prefiltration, sterile filtration of liquids and gases, mycoplasma, prion and virus clearance, endotoxin and DNA removal, and biomolecule purification and concentration. Products range from small laboratory- scale devices to large automated systems and filter test instruments. Pall's chromatography range includes membrane chromatography products already used on licensed products in the US and Europe, chromatography columns ranging from small pilot to fully engineered state-of-the-art columns, with fully automated axial compression packing up to 2.3 meters, packing and control systems, and full range of BioSepra media for ion exchange, affinity, hydroxy-apatite, hydrophobic charge induction, and size exclusion chromatography.

Pall's Scientific and Laboratory Services, and Validation Laboratory groups have been a cornerstone of support to its customers for more than 30 years. We employ more than 400 scientists, engineers and technicians in the Americas, Europe, Australia, and Asia.

Info #30

Division of Pall Corporation (PLL)

Pall Life Sciences 2200 Northern Blvd. East Hills,NY 11548




Europa House Havant Street Portsmouth PO1 3PD UK





lorem ipsum